Tagitanlimab
Tagitanlimab (HBM-9167) is a humanized anti-PD-L1 antibody (IgG1κ type) . Tagitanlimab selectively blocks the interaction of PD-L1 and PD-1. Tagitanlimab has the potential to be studied in recurrent or metastatic nasopharyngeal carcinoma (NPC) [1][2].
Product Specifications
CAS Number
[2417649-97-7]
Product Name Alternative
HBM-9167; KL-A167
UNSPSC
12352203
Target
PD-1/PD-L1
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/tagitanlimab.html
Purity
99.0
Solubility
10 mM in DMSO
Smiles
[Tagitanlimab]
Molecular Weight
(144.95 kDa)
References & Citations
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-P99544/Tagitanlimab-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-P99544/Tagitanlimab-SDS-MedChemExpress.pdf
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 3
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
